176 related articles for article (PubMed ID: 11699612)
1. Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation.
Fukatsu S; Yano I; Igarashi T; Hashida T; Takayanagi K; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K; Tanaka K; Inui K
Eur J Clin Pharmacol; 2001 Sep; 57(6-7):479-84. PubMed ID: 11699612
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
Lee JY; Hahn HJ; Son IJ; Suh KS; Yi NJ; Oh JM; Shin WG
Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation.
Nakagawa J; Ishido K; Tono Y; Kimura N; Wakiya T; Okamura Y; Hakamada K; Niioka T
Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):619-626. PubMed ID: 32514937
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
Staatz CE; Tett SE
Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
Zahir H; McLachlan AJ; Nelson A; McCaughan G; Gleeson M; Akhlaghi F
Ther Drug Monit; 2005 Aug; 27(4):422-30. PubMed ID: 16044097
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
Fukudo M; Yano I; Masuda S; Goto M; Uesugi M; Katsura T; Ogura Y; Oike F; Takada Y; Egawa H; Uemoto S; Inui K
Clin Pharmacol Ther; 2006 Oct; 80(4):331-45. PubMed ID: 17015051
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
[TBL] [Abstract][Full Text] [Related]
9. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients].
Zhang GM; Li L; Chen WQ; Bi SS; Liu X; Zhang XL; Lu W
Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Staatz CE; Willis C; Taylor PJ; Tett SE
Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
[TBL] [Abstract][Full Text] [Related]
11. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
12. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
Xue L; Rui JZ; Zhang Y; Miao LY
Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
Sam WJ; Aw M; Quak SH; Lim SM; Charles BG; Chan SY; Ho PC
Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292
[TBL] [Abstract][Full Text] [Related]
14. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
Antignac M; Hulot JS; Boleslawski E; Hannoun L; Touitou Y; Farinotti R; Lechat P; Urien S
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):409-16. PubMed ID: 15991041
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
Yang JW; Liao SS; Zhu LQ; Zhao Y; Zhang Y; Sun XY; Rao W; Qu W; Li WZ; Sun LY
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
[TBL] [Abstract][Full Text] [Related]
19.
Ji E; Kim MG; Oh JM
Ther Clin Risk Manag; 2018; 14():2119-2126. PubMed ID: 30498355
[TBL] [Abstract][Full Text] [Related]
20. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
